Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1031-2013Class II

Medtronic Prostiva RF Therapy Generator. The Prostiva RF system is indicated for the treatment of symptoms...

Medtronic Neuromodulation / initiated 2013-02-27 / Terminated / root cause: manufacturing process

Medtronic Neuromodulation began a recall of Medtronic Prostiva RF Therapy Generator. The Prostiva RF system is indicated for the treatment of symptoms due to urinary outflow obstruction secondary to... on . FDA classified it as Class II and gives the reason as "Medtronic has found through device testing that if the optional footswitch is not connected to the Model 8930 RF generator during use, an electrostatic discharge (i.e. static electricity) to the footswitch connector...". As of , the recall status on record is Terminated, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1031-2013
Classification
Class II
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Medtronic Neuromodulation
Product
Medtronic Prostiva RF Therapy Generator. The Prostiva RF system is indicated for the treatment of symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men over the age of 50 with prostate sizes between 20 and 50 cm3.
Product code
GEI Electrosurgical, Cutting & Coagulation & Accessories
Reason for recall
Medtronic has found through device testing that if the optional footswitch is not connected to the Model 8930 RF generator during use, an electrostatic discharge (i.e. static electricity) to the footswitch connector port may toggle the RF output on or off. If this were to occur, it could result in unintentionally starting or stopping the lesion process, depending on the current status of the equi
Root cause tag
manufacturing process
FDA root cause
Nonconforming Material/Component
Action
Medtronic sent a "Urgent Medical Device Correction" letter dated January 2013, to all affected customers. The letter identified the product the problem and the action needed to be taken by the customer. Medtronic has found through device testing that if the optional footswitch (Model 60883) is not connected to the Model 8930 RF generator during use, an electrostatic discharge (i.e. static electricity) to the footswitch connector port may toggle the RF output on or off. If this were to occur, it could result in unintentionally starting or stopping the lesion process, depending on the current status of the equipment. The status messages on the display screen and associated audible alarms operate as intended, and would notify the clinician of any change in status as described in chapter 2 of the system manual. Enclosed you will find an insulating cap that should be placed over the footswitch connector port when the Model 8930 RF Generator is used without the footswitch. The footswitch connector port is located on the rear panel of the Model 8930 RF Generator as shown below. For further questions In the United States, contact Medtronic Neuromodulation Technical Services at 1-800-707-0933 or your local product representative. Outside of the United States, contact your local product representative.
Quantity in commerce
848 (696 US, 152 OUS)
Distribution
Nationwide Distribution including Puerto Rico and all States in continental USA except ID, MT, and NH.
Product codes and lots
all Model 8930 radio frequency (RF) generators are affected

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1031-2013
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1031-2013Class IITerminatedVoluntary: Firm initiated